HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1-Reference-Cited by-同舟云学术

HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1

Published:2004-02 Issue:3 Volume:18 Page:495-502
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Pieniazek Danuta,Rayfield Mark,Hu Dale J,Nkengasong John N,Soriano Vincent,Heneine Walid,Zeh Clement,Agwale Simon M,Wambebe Charles,Odama Liliana,Wiktor Stefan Z

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference38 articles.

1. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology

2. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys

3. Sequence Note: Identification of a New HIV-2 Subtype Based on Phylogenetic Analysis of Full-Length Genomic Sequence

4. N-acetyl-cysteine and L-2-oxathiazolidine-4-carboxylic acid enhance contact-dependent growth of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and increase recovery of HIV from human-PBMC SCID mice

5. Predominance of Human Immunodeficiency Virus Type 2 Subtype B in Abidjan, Ivory Coast

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-2 Drug Resistance Genotyping from Dried Blood Spots;Journal of Clinical Microbiology;2020-12-17

2. Diagnosis of Human Immunodeficiency Virus Infection;Clinical Microbiology Reviews;2018-12-19

3. GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants;Antimicrobial Agents and Chemotherapy;2018-05

4. C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir;Journal of Virology;2016-03

5. A Modular System to Evaluate the Efficacy of Protease Inhibitors against HIV-2;PLoS ONE;2014-11-24